Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This study is designed to investigate the safety and tolerability of multiple doses of QAX576 in controlled or partially controlled asthma patients.

Phase 1/Phase 2

Novartis Pharmaceuticals